Fundz

Galvanize Therapeutics raises $130 million in an oversubscribed Series D round led by HealthQuest Capital to accelerate its commercial growth and advance PEF innovation.

PRIVATENov 16, 2026

Amount Raised

$130 Million

Round Type

Series D

San CarlosBiotechnologyHealth CareMedical Equipment Manufacturing

Investors

T. Rowe Price Associates, Inc.Fidelity Management & Research CompanyLongaeva PartnersJanus Henderson InvestorsPerceptive AdvisorsAlly Bridge GroupElevage Medical TechnologiesNorwest Venture PartnersSofinnova PartnersBraidwell LPOlympus Innovation VenturesHealthQuest Capital

Description

Galvanize Therapeutics has announced the closing of an oversubscribed $130 million Series D financing. The funding will support the commercial expansion, clinical evidence generation, and pipeline advancement of its pulsed electric field ablation technologies. Key milestones include FDA clearance and the launch of the next-generation Aliya EX Generator. The round was also joined by new investors Olympus Innovation Ventures and Braidwell LP, alongside existing investors.

Quick answer

Galvanize Therapeutics raised $130 Million in a Series D round, dated November 16, 2026. Investors: T. Rowe Price Associates, Inc., Fidelity Management & Research Company, Longaeva Partners, Janus Henderson Investors, Perceptive Advisors, Ally Bridge Group, Elevage Medical Technologies and Norwest Venture Partners. Galvanize Therapeutics is based in San Carlos, California, United States.

How much did Galvanize Therapeutics raise?
Galvanize Therapeutics raised $130 Million in a Series D round on November 16, 2026.
Who invested in Galvanize Therapeutics?
T. Rowe Price Associates, Inc., Fidelity Management & Research Company, Longaeva Partners, Janus Henderson Investors, Perceptive Advisors, Ally Bridge Group, Elevage Medical Technologies and Norwest Venture Partners are named as investors in this round.
What does Galvanize Therapeutics do?
Galvanize Therapeutics is developing therapies to deliver life-changing healthcare solutions to patients and their doctors at the convergence of biology, engineering, and care delivery.
Where is Galvanize Therapeutics based and how big is it?
Galvanize Therapeutics is based in San Carlos, California, United States. Fundz records about 134 employees.
Who are the decision-makers at Galvanize Therapeutics?
Fundz holds 1 contact at Galvanize Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical Equipment Manufacturing and Biotechnology around the same time

Companies in the same sectors as Galvanize Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Rezolute raised $94M (Post-IPO Equity) on November 16, 2026.
  • TestDynamics raised $9M (Series A) on November 16, 2026.
  • Raywatt raised $9.9M (Series B) on November 16, 2026.
  • 201 Therapeutics raised $178K (Seed) on November 16, 2026.
  • Seawolf Therapeutics raised $100M (Seed) on November 16, 2026.
  • SanMelix Laboratories (BeeCure) raised $1M (Pre-Seed) on November 16, 2026.

Who to call at Galvanize Therapeutics, and when

A new round usually means Galvanize Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Galvanize Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Galvanize Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Galvanize Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Galvanize Therapeutics

Location

San Carlos, California, United States

About

Galvanize Therapeutics is developing therapies to deliver life-changing healthcare solutions to patients and their doctors at the convergence of biology, engineering, and care delivery.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Galvanize Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Galvanize Therapeutics's next move

See what Strategic adds

Galvanize Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.